Eyenovia announces pricing of $5m registered direct offering

New york, june 28, 2024 (globe newswire) -- eyenovia, inc. (“eyenovia” or the “company”) (nasdaq: eyen), a commercial-stage ophthalmic company, announced today that it has entered into a securities purchase agreement with an institutional investor and its current largest stockholder, providing for the purchase and sale of 7,575,757 shares of common stock, and warrants to purchase up to 7,575,757 shares of common stock (the "offering"). the combined offering price for each share of common stock and accompanying warrant is $0.66.
EYEN Ratings Summary
EYEN Quant Ranking